Status:
WITHDRAWN
ELECTOR Treat-to-target Via Home-based Disease Activity Monitoring of Patients With Rheumatoid Arthritis
Lead Sponsor:
Frederiksberg University Hospital
Conditions:
Arthritis, Rheumatoid
Telerehabilitation
Eligibility:
All Genders
18-85 years
Phase:
NA
Brief Summary
The aim of this study is to explore whether the effectiveness of home-based disease activity monitoring via a home-based (eHealth) intervention is superior to standard clinical disease activity assess...
Detailed Description
The aim of RA therapy is to reduce disease activity, joint destruction, symptoms, and disability. The prevailing therapeutic approach is an aggressive pharmacological disease control, with readily ava...
Eligibility Criteria
Inclusion
- Patients diagnosed with rheumatoid arthritis
- Diagnosed with RA \> 12 months
- Age between 18 and 85 years
- Computer and Internet connection at home and ability to employ these
- Hand function that allows self-testing of blood test at home.
Exclusion
- Blood samples (creatinine, haemoglobin) outside lower normal limit - 5 % and upper normal limit + 5 % at screening.
- Blood samples (thrombocytes and leukocytes) outside lower normal limit - 15 % and upper normal limit + 15 % at screening
- Blood samples (ALT) outside lower normal limit - 100 % and upper normal limit + 100 % at screening
- Previously diagnosed with neutropenia and/or pancytopenia
- Dementia or other cognitive/physical deficiency that prevents participation
- Vision impairment that prevents the use of the devices and computer.
Key Trial Info
Start Date :
August 18 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 18 2020
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT03428763
Start Date
August 18 2020
End Date
August 18 2020
Last Update
February 27 2025
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Institute of Rheumatology, Charles University
Prague, Prague, Czechia, 128 50
2
The Parker Institute, Frederiksberg Hospital
Copenhagen, Denmark, 2000